Certara Gets Further FDA Grant For Virtual Bioequivalence Studies
US Agency Offers Funding To Verify And Expand Biosimulation Models
Executive Summary
The FDA has awarded biosimulation specialist Certara a further grant to verify and expand models for assessing virtual bioequivalence, to help enable safer, faster and more cost-effective generic drug development.